The neurotoxic effects of manganese on the dopaminergic innervation of the gill of the bivalve mollusc, Crassostrea virginica

Comparative Biochemistry and Physiology - C Toxicology and Pharmacology

Volumn 148, Issue 2, 2008, Pages 152-159

  Martin, Kesha ^a   Huggins, Turkesha ^a   King, Candice ^a   Carroll, Margaret A ^a   Catapane, Edward J ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Cilia; Crassostrea virginica; Dopamine; Ganglia; Gill; Manganese; Manganism; Serotonin

Indexed keywords

MANGANESE;

ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CILIARY MOTILITY; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; GANGLION; GILL; NEUROTOXICITY; NONHUMAN; OYSTER; PRIORITY JOURNAL;

ANIMALIA; BIVALVIA; CRASSOSTREA VIRGINICA; MOLLUSCA; OSTREIDAE;

EID: 45949083768     PISSN: 15320456     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpc.2008.05.004     Document Type: Article

References (105)

1. Abbe G.R., Riedel G.F., and Sanders J.G. Factors that influence the accumulation of copper and cadmium by transplanted eastern oysters (Crassostrea virginica) in the Patuxent River, Maryland. Mar. Environ. Res. 49 (2000) 377-396
2. Aiello E., and Sleigh M.A. The metachronal wave of lateral cilia of Mytilus edulis. J. Cell. Biol. 54 (1972) 493-506
3. Albers D.S., and Beal M.F. Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative diseases. J. Neural. Transm. Suppl. 59 (2000) 133-154
4. +3. Neurodegeneration 4 (1995) 329-334
5. Anantharam V., Kitazawa M., Wagner J., Kaul S., and Kanthasamy A.G. Caspase-3-dependent proteolytic cleavage of protein kinase C delta is essential for oxidative stress-mediated dopaminergic cell death after exposure to methylcyclopentadienyl manganese tricarbonyl. J. Neurosci. 22 (2002) 1738-1751
6. Andersen M.E., Gearhart J.M., and Clewell III H.J. Pharmacokinetic data needs to support risk assessments for inhaled and ingested manganese. Neurotoxicology 20 (1999) 161-171
7. Archibald F.S., and Tyree C. Manganese poisoning and the attack of trivalent manganese upon catecholamines. Arch. Biochem. Biophys. 256 (1987) 638-650
8. Aschner M. Manganese neurotoxicity and oxidative damage. Metals and Oxidative Damage in Neurological Disorders (1997), Plenum Press, New York 77-93
9. Aschner M. Manganese in health and disease: from transport to neurotoxicity. In: Massaro E. (Ed). Handbook of Neurotoxicology (2000), Humana Press, Totowa, NJ 195-209
10. Baek S.Y., Lee M.J., Jung H.S., Kim H.J., Lee C.R., Yoo C., Lee J.H., Lee H., Yoon C.S., Kim Y.H., Park J., Kim J.W., Jeon B.S., and Kim Y. Effect of manganese exposure on MPTP neurotoxicities. Neurotoxicology 24 (2003) 657-665
11. Barbeau A. Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C Cotzias). Neurotoxicology 5 (1984) 13-35
12. Barbeau A., Inoué N., and Cloutier T. Role of manganese in dystonia. In: Eldridge R., and Fahn S. (Eds). Advances in Neurol vol. 14 (1976), Raven Press, New York 339-352
13. Boening D.W. An evaluation of bivalves as biomonitors of heavy metal pollution in marine waters. Environ. Monit. Assess. 55 (1999) 459-470
14. Brenneman K.A., Cattley R.C., Ali S.F., and Dorman D.C. Manganese induced developmental neurotoxicity in the CD rat: is oxidative damage a mechanism of action?. Neurotoxicology 20 (1999) 477-488
15. Brouillet E.P.L., Shinobu U., McGarvey F., Hochberg F., and Beal M.F. Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism. Exp. Neurol. 120 (1993) 89-94
16. Bryan G.W., and Hummerstone L.G. Brown seaweed as an indicator of heavy metals in estuaries in south-west England. J. Mar. Biol. Assoc. U.K. 53 (1973) 705-720
17. Bu-Olayan A.H., and Subrahmanyam M.N. Accumulation of copper, nickel, lead and zinc by snail, Lunella coronatus and pearl oyster, Pinctada radiata from the Kuwait coast before and after the Gulf War oil spill. Sci. Total Environ. 197 (1997) 161-165
18. Calabrese A., Collier R.S., Nelson D.A., and MacInnes J.R. The toxicity of heavy metals to embryos of the American oyster Crassostrea virginica. Mar. Biol. 18 (1973) 162-166
19. Calne D.B., Chu N.S., Huang C.C., Lu C.S., and Olanow W. Manganism and idiopathic parkinsonism: similarities and difference. Neurology 44 (1994) 1583-1586
20. Canterford G.S., and Canterford D.R. Toxicity of heavy metals to the marine diatom Ditylum brightwellii (West) Grunow: correlation between toxicity and metal speciation. J. Mar. Biol. Assoc. U.K. 60 (1980) 227-242
21. Cantuti-Castelvetri I., Shukitt-Hale B., and Joseph J.A. Dopamine neurotoxicity: age dependent behavioral and histological effects. Neurobiol. Aging 24 (2003) 697-706
22. Capar S.G., and Yess N.J. US Food and Drug Administration survey of cadmium, lead and other elements in clams and oysters. Food Addit. Contam. 13 (1996) 553-560
23. Carroll M.A., and Catapane E.J. The nervous system control of lateral ciliary activity of the gill of the bivalve mollusc, Crassostrea virginica. Comp. Biochem. Physiol. A 148 (2007) 445-450
24. Catapane E.J., Stefano G.B., and Aiello E. Pharmacological study of the reciprocal dual innervation of the lateral ciliated gill epithelium by the CNS of Mytilus edulis (Bivalvia). J. Exp. Biol. 74 (1978) 101-113
25. Cersosimo M.G., and Koller W.C. The diagnosis of manganese-induced parkinsonism. NeuroToxicology 27 (2006) 340-346
26. Chen L., Ding Y., Cagniard B., Van Laar A.D., Mortimer A., Chi W., Hastings T.G., Kang U.J., and Zhuang X. Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice. J. Neurosci. 28 (2008) 425-433
27. Cotzias G.C. Manganese in health and disease. Physiol. Rev. 38 (1958) 503-532
28. Couper J. On the effects of black oxide of manganese when inhaled into the lungs. Br. Ann. Med. Pharmacol. 1 (1837) 41-42
29. Dauer W., and Przedborski S. Parkinson's disease: mechanisms and models. Neuron 39 (2003) 889-909
30. Davis J.M. Inhalation health risks of manganese: an EPA perspective. Neurotoxicology 20 (1999) 511-518
31. Dawson T.M., and Dawson V.L. Molecular pathways of neurodegeneration in Parkinson's disease. Science 302 (2003) 819-822
32. Dobson A.W., Erikson K.M., and Aschner M. Manganese neurotoxicity. Ann. N.Y. Acad. Sci. 1012 (2004) 115-128
33. Donaldson J. The physiopathologic significance of manganese in brain: its relation to schizophrenia and neurodegenerative disorders. Neurotoxicology 8 (1987) 451-462
34. Dorman D.C., Melanie, Struve F., Clewell III H.J., and Andersen M.E. Application of pharmacokinetic data to the risk assessment of inhaled manganese. Neurotoxicology 27 (2006) 752-764
35. Downer N., Myrthil M., Nduka E., Lecky D., and Catapane E.J. Effects of acute temperature stress on the distribution of biogenic amines in the American oyster, Crassostrea virginica. Annals of the 2006 SICB Conference, abstract P2.100 (2006)
36. Eaton A. The impact of anoxia on Mn fluxes in the Chesapeake Bay. Geochim. Cosmochim. Acta 43 (1979) 429-432
37. Eisler R. Acute toxicities of selected heavy metals to the softshell clam, Mya arenaria. Bull. Environ. Contam. Toxicol. 17 (1977) 137-144
38. Emerit J., Edeas M., and Bricaire F. Neurodegenerative diseases and oxidative stress. Biomed. Pharmacother. 58 (2004) 39-46
39. Eriksson H., Gillberg P.G., Aquilonius S.M., Hedstriim K.G., and Heilbronn E. Receptor alteration in manganese intoxicated monkeys. Arch. Toxicol. 66 (1992) 359-364
40. Eriksson H., Magiste K., Plantin L.O., Fonnum F., Hedstrtm K., Theodorsson G., Norheim E., Kristensson K., Stalberg E., and Heilbronn E. Effects of manganese oxide on monkeys as revealed by a combined neurochemical, histological and neurophysiological evaluation. Arch. Toxicol. 61 (1987) 46-52
41. Fahn S., and Cohen G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol. 32 (1992) 804-812
42. Fang Z.Q., Cheung R.Y.H., and Wong M.H. Heavy metal concentrations in edible bivalves and gastropods avilable in the major markets of the Pearl River Delta. J. Environ. Sci. 13 (2001) 210-217
43. Folsom T.R., Young D.R., Johnson J.N., and Pillai K.C. Manganese-54 and zinc-65 in coastal organisms of California. Nature 200 (1963) 327-329
44. Fotopoulou M.A., and Ioannou P.C.P. Post-column terbium complexation and sensitized fluorescence detection for the determination of norepinephrine, epinephrine and dopamine using high-performance liquid chromatography. Anal. Chim. Acta 462 (2002) 179-185
45. Galvani P., Fumagalli P., and Santagostino A. Vulnerability of mitochondrial complex I in PC12 cells exposed to manganese. Eur. J. Pharmacol. 293 (1995) 377-383
46. Gorell J.M., Rybicki B.A., Cole Johnson C., and Peterson E.L. Occupational metal exposures and the risk of Parkinson's disease. Neuroepidemiology 18 (1999) 303-308
47. Graham D.G. Catecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease. Neurotoxicology 5 (1984) 83-95
48. Guilarte T.R., Ming-Kai C., McGlothan J.L., Verina T., Wong D.F., Zhou Y., Alexander M., Rohde C.A., Syversen T., Decamp E., Koser A.J., Fritz S., Gonczi H., Anderson D.W., and Schneider J.S. Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates. Exp. Neurol. 202 (2006) 381-390
49. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59 (1992) 1609-1623
50. HaMai D., and Bondy S.C. Oxidative basis of manganese neurotoxicity. Ann. N. Y.Acad. Sci 1012 (2004) 129-141
51. Hornykiewicz O. Dopamine and extrapyramidal motor function and dysfunction. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 50 (1972) 390-415
52. Huang C.C., Chu N.S., Lu C.S., Wang J.D., Tsai J.L., and Tzeng J.L. Chronic manganese intoxication. Arch. Neurol. 46 (1989) 1104-1106
53. Huang C.C., Lu C.S., Chu N.S., Hochberg F., Lilienfeld D., and Olanow W. Progression after chronic manganese exposure. Neurology 43 (1993) 1479-1483
54. Huang C.C., Chu N.S., Lu C.S., Chen R.S., and Calne D.B. Long-term progression in chronic manganism - ten years follow-up. Neurology 50 (1998) 698-700
55. International Program on Chemical Safety (IPCS). Manganese and its compounds: environmental aspects. Concise International Chemical Assessment Document (Cicads) 63 (2004), World Health Organization, Geneva, Switzerland. http://www.inchem.org/documents/cicads/cicads/cicad63.htm#app4 http://www.inchem.org/documents/cicads/cicads/cicad63.htm#app4
56. Iregren A. Manganese neurotoxicity in industrial exposures: proof of effects, critical exposure level, and sensitive tests. Neurotoxicology 20 (1999) 315-324
57. Jankovic J. Searching for a relationship between manganese and welding and Parkinson's disease. Neurology 64 (2005) 2021-2028
58. Kaiser J. Manganese: a high octane dispute. Science 300 (2003) 926-928
59. Koller W.C., Lyons K.E., and Truly W. Effect of levodopa treatment for Parkinsonism in welders. A double-blind study. Neurology 62 (2004) 730-733
60. Latchoumycandane C., Anantharam V., Kitazawa M., Yang Y., Kanthasamy A., and Kanthasamy A.G. Protein kinase C delta is a key downstream mediator of manganese-induced apoptosis in dopaminergic neuronal cells. J. Pharmacol. Exp. Therap. 313 (2005) 46-55
61. Levy B.S., and Nassetta W.J. Neurological effects of manganese in humans: a review. Int. J. Occup. Environ. Health 9 (2003) 153-163
62. Lotharius J., and Brundin P. Pathogenesis of Parkinson's disease. Dopamine, vesicles and alpha-synuclein. Nat. Rev. Neurosci. 3 (2002) 932-942
63. Lu C.S., Huang C.C., Chum N.S., and Calne D.B. Levodopa failure in chronic manganism. Neurology 44 (1994) 1600-1602
64. Lucchini R., Apostoli P., Perrone C., Placidi D., Albini E., and Migliorati P. Long-term exposure to "low levels" of manganese oxides and neurofunctional changes in ferroalloy workers. Neurotoxicity 20 (1999) 287-297
65. Malanga C.J. Dopaminergic stimulation of frontal ciliary activity in the gill of Mytilus edulis. Comp. Biochem. Physiol. C 51 (1975) 25-34
66. Meco G., Bonfanti V., Vanacore N., and Fabrizio E. Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate. Scand. J. Work. Environ. Health 20 (1994) 301-305
67. Mena I., Marin O., Fuenzalida S., and Cotzias G.C. Chronic manganese poisoning. Clinical picture and manganese turnover. Neurology 17 (1967) 128-136
68. Mena I., Court J., Fuenzalida S., Papavasiliou P.S., and Cotzias G.S. Modification of chronic manganese poisoning. N. Engl. J. Med. 282 (1970) 5-10
69. Mergler D. Manganese: the controversial metal. At what levels can deleterious effects occur?. Can. J. Neurol. Sci. 23 (1996) 93-94
70. Mergler D. Neurotoxic effects of low level exposure to manganese in human populations. Environ. Res. 80 (1999) 99-102
71. Milatovic D., Yin Z., Gupta R.C., Sidoryk M., Albrecht J., Aschner J.L., and Aschner M. Manganese induces oxidative impairment in cultured rat astrocytes. Toxicol. Sci. 98 (2007) 198-205
72. Murray S., Lovell A., Carroll M.A., and Catapane E.J. Distribution of manganese in the oyster Crassostrea virginica raised in Jamaica Bay, NY and its accumulations in oysters acutely exposed to high levels. Annals of the 2007 SICB Conference (2007)
73. Nagatomo S., Umehara F., Hanada K., Nobuhara Y., Takenaga S., Arimura K., and Osame M. Manganese intoxication during total parenteral nutrition: report of two cases and review of the literature. J. Neurolog. Sci. 162 (1999) 102-105
74. National Academy of Sciences. Medical and Biological Effects of Environmental Pollutants: Manganese (1973), National academy Press, Wash. DC 1-101
75. Neff N.H., Barrett R.E., and Costa E. Selective depletion of caudate nucleus dopamine and serotonin during chronic manganese dioxide administration to squirrel monkeys. Experientia 25 (1969) 1140-1141
76. Newland M.C. Animal models of manganese's neurotoxicity. Neurotoxicology 20 (1999) 415-432
77. Olanow C.W. Manganese-induced parkinsonism and Parkinson's disease. Ann. N.Y. Acad Sci 1012 (2004) 209-223
78. Ostiguy C., Asselin P., and Malo S. The emergence of manganese-related health problems in Quebec: an integrated approach to evaluation, diagnosis, management and control. Neuro0oxicology 27 (2006) 350-356
79. Pal P.K., Samii A., and Calne D.B. Manganese neurotoxicity: a review of clinical features. Neurotoxicology 20 (1999) 227-238
80. Parenti M., Flauto C., Parati E., Vescovi A., and Groppetti A. Manganese neurotoxicity: effects of L-DOPA and pargyline treatments. Brain Res. 367 (1986) 8-13
81. Pentreath R.J. The accumulation from water of 65Zn, 54Mn, 58Co, and 59Fe by the mussel, Mytilus edulis. J Mar. Biol. Assoc. U.K. 53 (1973) 127-143
82. Phillips D., and Rainbow P. Biomonitoring of Trace Aquatic Contaminants (1993), Elsevier Applied Science, London 371
83. Przedborski S., Kostic V., Jackson-Lewis V., Naini A.B., Simonetti S., and Fahn S. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J. Neurosci 12 (1992) 1658-1667
84. Racette B.A., Tabbal S.D., Jennings D., Good L., Perlmutter J.S., and Evanoff B. Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders. Neurology 64 (2005) 230-235
85. Rai U.N., and Chandra P. Accumulation of copper, lead, manganese and iron by field populations of Hydrodictyon reticulatum (Linn.) Lagerheim. Sci. Total Environ. 116 (1992) 203-211
86. Rainbow P.S. The significance of trace metal concentrations in marine invertebrates. In: Dallinger R., and Rainbow P.S. (Eds). Ecotoxicology of Metals in Invertebrates (1993), Lewis Publishers, Boca Raton, Florida 3-23
87. Reidy T.J., Bowler R.M., Rauch S.S., and Pedroza G.I. Pesticide exposure and neuropsychological impairment in migrant farm workers. Arch Clin Neuropsychol 7 (1992) 85-95
88. Reimer, P.S. 1999. Environmental effects of manganese and proposed freshwater guidelines to protect aquatic life in British Columbia [MSc thesis]. Vancouver, B.C., University of British Columbia.
89. Rodney E., Herrera P., Luxama J., Boykin M., Crawford A., Carroll M.A., and Catapane E.J. Bioaccumulation and tissue distribution of arsenic, cadmium, copper and zinc in Crassostrea virginica grown at two different depths in Jamaica Bay, New York. In Vivo 29 (2007) 16-27
90. Rosenstock H.A., Simons D.G., and Meyer J.S. Chronic manganism. Neurologic and laboratory studies during treatment with levodopa. JAMA 217 (1971) 1354-1358
91. Sadek A.H., Rauch R., and Schulz P.E. Parkinsonism due to manganism in a welder. Int J Toxicol 22 (2003) 393-401
92. Scanes P.R., and Roach A.C. Determining natural background concentrations of trace metals in oysters from New South Wales, Australia. Environ. Pollut. 105 (1999) 437-446
93. Schulz J.B., Lindenau J., Seyfried J., and Dichgans J. Glutathione, oxidative stress and neurodegeneration. Eur. J. Biochem. 267 (2000) 4904-4911
94. Shi X.L., and Dalal N.S. The glutathionyl radical formation in the reaction between manganese and glutathione and its neurotoxic implications. Med-Hypoth 33 (1990) 83-87
95. Sistrunk S.C., Ross M.K., and Filipov N.M. Direct effects of manganese compounds on dopamine and its metabolite DOPAC: an in vivo study. Environ. Toxicol. Pharmacol. 23 (2007) 286-296
96. Sloot W.N., Korf J., Koster J.F., DeWit L.E.A., and Gramsbergen J.B.P. Manganese-induced hydroxyl radical formation in rat striatum is not attenuated by dopamine depletion or iron chelation in vivo. Exp. Neurol. 138 (1996) 236-245
97. Spooner D.R., Maher W., and Otway N. Trace metal concentrations in sediments and oysters of Botany Bay, NSW, Australia. Arch. Environ. Contam. Toxicol. 45 (2003) 0092-0101
98. Stefano G.B., Catapane E.J., and Aiello E. Dopaminergic agents: influence on serotonin in molluscan nervous system. Science 194 (1976) 539-541
99. Stredrick D.L., Stokes A.H., Worst T.J., Freeman W.H., Johnson E.A., Lash L.H., Aschner M., and Vrana K.E. Manganese-induced cytotoxicity in dopamine-producing cells. Neurotoxicology 25 (2004) 543-553
100. Takeda A. Manganese action in brain function. Brain Res. Rev. 41 (2003) 79-87
101. Thompson S.E., Burton C.A., Quinn D.J., and Ng Y.C. Concentration Factors of Chemical Elements in Edible Aquatic Organisms (1972), University of California, Lawrence Livermore Laboratory, Bio-Medical Division, Livermore, CA
102. US EPA. Health assessment document for manganese. Final draft. Cincinnati, OH, US Environmental Protection Agency, Office of Research and Development (Report No. EPA/600/8-83/013F) (1984)
103. Vescovi A., Facheris L., Zaffaroni A., Malanca G., and Parati E.A. Dopamine metabolism alterations in a manganese-treated pheochromocytoma cell line (PC12). Toxicology 67 (1991) 129-142
104. Wedler F.C. Biological significance of manganese in mammalian systems. Progr. Med. Chem. 30 (1993) 89-133
105. Zeri C., Voutsinou-Taliadouri F., Romanov A.S., Ovsjany E.I., and Moriki A. A comparative approach of dissolved trace element exchange in two interconnected basins: Black Sea and Aegean Sea. Mar. Pollut. Bull. 40 (2000) 666-673